top of page


Therapeutic Areas

Aganitha accelerates drug discovery and development with AI and Cloud powered in silico solutions for:

  1. Multi-omics (GWAS, scRNA-seq, Proteomics, …) studies in disease research

  2. De novo design, optimization and development of small molecule (SMOL), antibodies, gene & RNA therapies

  3. Process R&D for synthesis of small molecules and biologicals

AI-Enabled Services:

  • Research services that use machine learning (ML) algorithms

  • Research services that use large language models (LLM)

  • Research services that use natural language processing (NLP)

  • Data services that use ML, LLMs or NLP

Utilize Aganitha AI technologies in the following spaces:

  • Biology, including target discovery, imaging and HTS

  • Chemistry, including analytical chemistry, manufacturing & medicinal chemistry

  • Pharmacology, including in vitro and in vivo disease models

  • Drug Metabolism, including pharmacokinetics and ADME

  • Data, including data transfer, analysis and storage

bottom of page